Published in Virology on November 01, 1974
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A (1985) 2.56
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol (1995) 1.89
Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J Virol (1985) 1.87
Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J Virol (1989) 1.68
The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol (1988) 1.60
Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol (1988) 1.27
Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity. J Virol (1987) 1.26
Relationship between hemagglutinin and sialidase from Clostridium perfringens CN3870: chromatographic characterization of the biologically active proteins. J Bacteriol (1976) 1.02
Isolation of the dengue virus envelope glycoprotein from membranes of infected cells by concanavalin A affinity chromatography. J Virol (1976) 0.99
Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein. Infect Immun (1982) 0.98
Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein. J Virol (2006) 0.90
Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins. Infect Immun (1980) 0.90
Mutations in multiple domains activate paramyxovirus F protein-induced fusion. J Virol (2004) 0.88
Nucleotide and predicted amino acid sequence analysis of the fusion protein and hemagglutinin-neuraminidase protein genes among Newcastle disease virus isolates. Phylogenetic relationships among the Paramyxovirinae based on attachment glycoprotein sequences. Funct Integr Genomics (2004) 0.87
Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations. Infect Immun (1979) 0.85
Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses. Expert Rev Vaccines (2015) 0.80
Role of cellular proteases in viral pathogenicity. Trans Am Clin Climatol Assoc (1979) 0.79
Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology (1975) 6.90
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis (1980) 4.61
Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity. Virology (1969) 4.45
Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology (1977) 4.33
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
Evidence for a ninth influenza viral polypeptide. Virology (1978) 4.21
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology (1972) 4.05
An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. Virology (1966) 4.03
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology (1971) 3.96
On the role of the response of the cell membrane in determining virus virulence. Contrasting effects of the parainfluenza virus SV5 in two cell types. J Exp Med (1966) 3.71
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology (1980) 3.53
Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol (1973) 3.49
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med (1980) 3.32
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology (1976) 3.13
A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A (1983) 3.08
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci U S A (1979) 2.58
Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1970) 2.58
On the role of microtubules in movement and alignment of nuclei in virus-induced syncytia. J Cell Biol (1968) 2.53
Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J (2001) 2.51
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology (1977) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Isolation and properties of the helical nucleocapsid of the parainfluenza virus SV5. Proc Natl Acad Sci U S A (1967) 2.46
Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1971) 2.44
The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion. Virology (1970) 2.37
Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1979) 2.33
Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology (1981) 2.26
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology (1979) 2.20
Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17
Horizontal transmission of HIV infection between two siblings. Lancet (1986) 2.17
A comparison of the polypeptides of four measles virus strains. Virology (1977) 2.15
Activation of the Sendai virus fusion protein (f) involves a conformational change with exposure of a new hydrophobic region. J Biol Chem (1981) 2.04
Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology (1973) 2.01
Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology (1983) 2.00
Cell-fusing activity of visna virus particles. Virology (1967) 1.98
Protease activation mutants of sendai virus. Activation of biological properties by specific proteases. Virology (1976) 1.95
Immunological studies of the functions of paramyxovirus glycoproteins. Virology (1981) 1.93
the relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptide. Virology (1981) 1.85
Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus. J Virol (1970) 1.85
Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Proc Natl Acad Sci U S A (1982) 1.85
Involvement of microtubules and 10-nm filaments in the movement and positioning of nuclei in syncytia. J Cell Biol (1979) 1.78
In vitro synthesis of structural and nonstructural proteins of Sendai and SV5 viruses. Virology (1980) 1.78
Conformation of the helical nucleocapsids of paramyxoviruses and vesicular stomatitis virus: reversible coiling and uncoiling induced by changes in salt concentration. Proc Natl Acad Sci U S A (1980) 1.76
Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs. Proc Natl Acad Sci U S A (1987) 1.75
The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology (1980) 1.69
Plaque assay of Visna virus using a secondary cellular overlay as an indicator. Virology (1967) 1.68
Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities. J Gen Virol (1971) 1.62
Measles virus polypeptides synthesis in infected cells. Virology (1978) 1.61
Infection with paramyxoviruses stimulates synthesis of cellular polypeptides that are also stimulated in cells transformed by Rous sarcoma virus or deprived of glucose. Proc Natl Acad Sci U S A (1978) 1.55
Congenital infections with human herpesvirus 6. J Infect Dis (1998) 1.51
Synthesis of influenza virus polypeptides in cells resistant to alpha-amanitin: evidence for the involvement of cellular RNA polymerase II in virus replication. J Virol (1977) 1.49
Proteolytic cleavage of subunits of the nucleocapsid of the paramyxovirus simian virus 5. J Virol (1974) 1.49
Measles-virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis: absence of the M protein. N Engl J Med (1981) 1.48
Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis. Virology (1979) 1.48
Plasma membrane lipids and parainfluenza virus assembly. Virology (1970) 1.44
Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. Virology (1973) 1.43
Replication of SV5 RNA and the effects of superinfection with poliovirus. Virology (1967) 1.43
The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. RNA (2001) 1.42
Chemical composition of the parainfluenza virus SV5. Virology (1969) 1.39
The RNAs of infective and incomplete influenza virions grown in MDBK and HeLa cells. Virology (1970) 1.37
The length of the helical nucleocapsid of Newcastle disease virus. Virology (1967) 1.36
Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation. Infect Immun (1978) 1.32
Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J Virol (1996) 1.32
A comparison of immune cytolysis and virus-induced fusion of sensitive and resistant cell types. Proc Soc Exp Biol Med (1969) 1.31
The nucleic acid of the parainfluenza virus SV5. Virology (1968) 1.30
Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein. Proc Natl Acad Sci U S A (1984) 1.30
Studies on the helical nucleocapsid of influenza virus. Virology (1982) 1.27
Studies on pneumonia virus of mice (PVM) in cell culture. I. Replication in baby hamster kidney cells and properties of the virus. J Exp Med (1967) 1.25
Studies on pneumonia virus of mice (PVM) in cell culture. II. Structure and morphogenesis of the virus particle. J Exp Med (1967) 1.24
The carbohydrate structure of the glycoproteins of the paramyxovirus SV5 grown in bovine kidney cells. J Biol Chem (1979) 1.22
Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J Virol (1995) 1.20
The synthesis of Sendai virus polypeptides in infected cells. II. Intracellular distribution of polypeptides. Virology (1977) 1.14
Fusion of Sendai virus with liposomes: dependence on the viral fusion protein (F) and the lipid composition of liposomes. Virology (1983) 1.14
The transcriptase complex of the paramyxovirus SV5. Virology (1977) 1.12